Overview and determinants of cardiovascular disease in indigenous populations

Leonard Kritharides1, Alex Brown, David Brieger

  • 1University of Sydney, Sydney, Australia. leonard.kritharides@sydney.edu.au

Insights

Cardiovascular disease (CV) poses a significant global health challenge for Indigenous populations. Understanding its causes worldwide is crucial for improving health outcomes in Australia and New Zealand.

Area of Science:

  • Global Health
  • Cardiovascular Health
  • Indigenous Health

Background:

  • Cardiovascular disease (CV) is a major health concern affecting 400 million Indigenous people globally.
  • The World Health Organization (WHO) identified non-communicable diseases, including CV disease, as a priority in its 2008-2013 Action Plan.
  • Addressing CV disease in Indigenous populations worldwide is essential for improving health equity.

Purpose of the Study:

  • To highlight the global burden of cardiovascular disease (CV) in Indigenous populations.
  • To emphasize the importance of international collaboration in understanding CV disease in Indigenous communities.
  • To set the stage for discussions on Indigenous cardiovascular health at the Inaugural CSANZ Conference.

Main Methods:

  • The study is based on scientific presentations from international experts at a conference.
  • Focus on global perspectives on Indigenous cardiovascular health.
  • Discussions informed by speakers committed to addressing Indigenous health as a global issue.

Main Results:

  • Cardiovascular disease (CV) is a significant and widespread issue among global Indigenous populations.
  • International expertise highlights the interconnectedness of Indigenous health challenges worldwide.
  • The conference served as a platform to address the global problem of Indigenous cardiovascular health.

Conclusions:

  • A comprehensive understanding of global Indigenous cardiovascular disease (CV) is necessary.
  • International collaboration and shared knowledge are vital for tackling CV disease in Indigenous communities.
  • Continued focus on Indigenous health equity is paramount for global public health initiatives.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...